Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Bologna
Clinical trial register · Italy

Clinical Trials in Bologna, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6791 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:19 UTC
6791
Studies in scope
all four open statuses
4079
Recruiting now
open to new participants
1019
Lead sponsors
across recruiting studies
Top sites
Milan 137 Naples 79 Roma 71 Florence 57 Padova 56
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna306 Istituto Ortopedico Rizzoli106 AstraZeneca45 Eli Lilly and Company30 Janssen Research & Development, LLC26 Clear sponsor filter
Site location
Milan137 Naples79 Roma71 Florence57 Padova56
All 111 locations
Target enrolment
to

Trials with a site in Bologna

45 of 6791 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Recruiting
AstraZeneca
Phase 3
2,800
Bari, Bologna, Cosenza, Cremona, Genoa, Milan, Modena, Naples
2026-09-01
Not yet open
AstraZeneca
Phase 3
750
Bologna, Milan, Rome, Rozzano, Torino
2026-08-25
Recruiting
AstraZeneca
Phase 3
7,000
Alessandria, Bari, Bologna, Catania, Chieri, Cinisello Balsamo, Cosenza, Eboli
2026-08-21
Recruiting
AstraZeneca
Phase 3
2,500
Bologna, Milan, Palermo, Pisa, Roma, Rozzano, Sesto San Giovanni, Torino
2026-08-19
Recruiting
AstraZeneca
Phase 3
1,200
Bari, Bologna, Chieti, Milan, Modena, Naples, Roma
2026-07-06
Recruiting
AstraZeneca
Phase 3
4,500
Bologna, Catania, Chieti, Florence, Latina, Milan, Pisa, Ravenna
2026-06-29
Recruiting
AstraZeneca
Phase 3
750
Bologna, Milan, Rome, Rozzano, Torino
2026-06-26
Active, closed
AstraZeneca
Phase 2
326
Bologna, Florence, Milan, Padova, Pavia, Pisa, Torino, Torrette - Ancona
2026-06-11
Recruiting
AstraZeneca
Phase 3
508
Bologna, Milan, Naples, Rozzano, Torino
2026-02-23
Recruiting
AstraZeneca
Phase 1/2
84
Bologna, Ravenna
2026-01-09
Recruiting
AstraZeneca
Observational
335
Salerno, Padova, Teramo, Treviso, Varese, Bari, Bergamo, Bologna
2025-12-20
Recruiting
AstraZeneca
Phase 1/2
91
Bologna, Milan
2025-09-24
Recruiting
AstraZeneca
Phase 3
250
Bologna, Brescia, Florence, Milan, Torino
2025-08-07
Recruiting
AstraZeneca
Phase 3
800
Alessandria, Aviano, Bari, Bologna, Catania, Florence, Haifa, Milan
2025-08-01
Recruiting
AstraZeneca
Phase 3
15,100
Altamura, Arzignano, Bergamo, Bologna, Brescia, Caserta, Catania, Cona
2025-06-04
Recruiting
AstraZeneca
Phase 3
1,220
Bologna, Milan, Palermo, Perugia, Pisa, Roma, Rozzano
2025-05-06
Recruiting
AstraZeneca
Phase 2
80
Bologna, Castelfranco Veneto, Florence, Milan, Naples, Pavia, Pisa, Roma
2025-03-12
Recruiting
AstraZeneca
Phase 3
5,000
Bassano del Grappa, Bologna, Desio, Foggia, Genoa, Modena, Naples, Novara
2025-03-03
Recruiting
A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
NCT06564038Chronic Lymphocytic Leukaemia, Small Lymphocytic Lymphoma, Mantle-cell Lymphoma, Large B-cell Lymphoma
DrugsSurovatamig·Acalabrutinib·Vincristine·Doxorubicin
AstraZeneca
Phase 1/2
408
Bologna, Milan
2025-01-30
Active, closed
AstraZeneca
Phase 3
181
Bologna, Catania, Florence, Padua, Pisa, Roma, Rozzano
2024-12-03
Recruiting
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
NCT06526793B-cell Non-Hodgkin Lymphoma, Follicular Lymphoma (FL), Large B-Cell Lymphoma (LBCL)
DrugSurovatamig
AstraZeneca
Phase 2
270
Alessandria, Bologna, Busto Arsizio, Milan, Roma
2024-11-27
Recruiting
AstraZeneca
Phase 1/2
174
Bologna, Milan
2024-09-18
Recruiting
AstraZeneca
Phase 3
788
Bergamo, Bologna, Milan, Modena, Naples, Padova, Reggio Emilia, Rome
2024-08-01
Active, closed
AstraZeneca
Phase 3
2,554
Bologna, Catanzaro, Chiavari, Desio, Milan, Naples, Parma, Rozzano
2024-03-29
Active, closed
AstraZeneca
Phase 2
142
Bari, Bologna, Milan, Naples, Palermo, Pavia, Peschiera del Garda
2024-02-22
Recruiting
AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
NCT06137144Lymphoma, Non-Hodgkin Lymphoma, Hodgkin Lymphoma, Peripheral T-cell Lymphoma (PTCL)
DrugsAZD3470·Keytruda·Pembrolizumab
AstraZeneca
Phase 1/2
161
Alessandria, Bologna, Milan
2024-01-23
Recruiting
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
NCT06137118B-cell Acute Lymphoblastic Leukemia (B-ALL)
DrugSurovatamig
AstraZeneca
Phase 1/2
255
Bergamo, Bologna, Monza, Naples, Roma
2023-12-29
Active, closed
AstraZeneca
Phase 3
1,835
Bergamo, Bologna, Foggia, Genoa, Naples, Pisa, Roma, Torino
2023-11-07
Active, closed
AstraZeneca
Phase 3
5,511
Bergamo, Bologna, Florence, Genoa, Meldola, Milan, Misterbianco, Monza
2023-10-05
Recruiting
AstraZeneca
Phase 3
800
Bari, Bologna, Catania, Florence, Lecco, Milan, Monza, Naples
2023-09-22
Active, closed
AstraZeneca
Phase 3
1,174
Bologna, Brescia, Florence, Genova, Livorno, Meldola, Messina, Milan
2022-11-28
Active, closed
AstraZeneca
Phase 3
368
Bologna, Milan, Naples, Padova, Pisa, Roma, Rozzano, Verona
2022-11-10
Active, closed
AstraZeneca
Phase 3
148
Arezzo, Avellino, Bari, Bologna, Florence, Meldola, Milan, Naples
2021-10-28
Active, closed
AstraZeneca
Phase 3
927
Bologna, Candiolo, Livorno, Milan, Naples, Negrar, Padova, Roma
2021-10-25
Active, closed
AstraZeneca
Phase 3
732
Bologna, Candiolo, Florence, Meldola, Milan, Naples, Padova, Prato
2021-10-18
Active, closed
AstraZeneca
Phase 3
315
Bergamo, Bologna, Florence, Meldola, Milan, Misterbianco, Naples, Padova
2021-06-30
Active, closed
AstraZeneca
Phase 3
893
Bologna, Florence, Misterbianco, Naples, Padova, Prato, Roma
2021-05-10
Active, closed
AstraZeneca
Phase 1/2
245
Bologna, Milan, Naples, Rome
2020-12-28
Active, closed
AstraZeneca
Phase 3
185
Ancona, Bologna, Brescia, Candiolo, Catania, Lecce, Lecco, Milan
2020-08-04
Active, closed
AstraZeneca
Phase 3
134
Bologna
2020-07-20
Active, closed
AstraZeneca
Phase 2
240
Bologna, Catanzaro, Meldola, Messina, Milan, Monza, Naples, Roma
2020-04-22
Active, closed
AstraZeneca
Phase 3
1,063
Bari, Bologna, Florence, Milan, Naples, Orbassano, Pozzuoli, Verona
2018-11-16
Active, closed
AstraZeneca
Phase 2
273
Ancona, Bologna, Brescia, Cona, Genova, Lecco, Meldola, Messina
2018-03-07
Active, closed
AstraZeneca
Phase 3
682
Bari, Bergamo, Bologna, Cremona, Florence, Lucca, Meldola, Milan
2015-10-21
Active, closed
AstraZeneca
Phase 3
1,837
Bergamo, Bologna, Bolzano, Castellanza Varese, Lecce, Legnago, Milan, Modena
2014-04-22
Rows per page Showing 1–45 of 45
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 October 2026. https://priyalifescience.com/clinical-trials-italy/city/bologna

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,791 studies in total at the last sync on 11 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 45 of those studies with a site in Bologna that also match the filters currently applied.

How many clinical trials are recruiting in Bologna?

23 of the 45 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:19 UTC sync. A further 1 have not yet opened recruitment, 21 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Bologna), 45 studies
PhaseStudiesRecruitingShare
Phase 3311468.9%
Phase 1/27615.6%
Phase 26213.3%
Observational112.2%

Most active sponsors

Lead sponsors with the most studies (Bologna)
Lead sponsorStudiesRecruiting
AstraZeneca4523
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.